Performance of Two Sclera Fixated Intraocular Lens Concepts
Carlevale
1 other identifier
observational
26
1 country
1
Brief Summary
To evaluate and compare the post-operative outcome of two different sceral fixated IOL concepts, the Yamane method (ZA9003, J\&J, USA) and the Carlevale IOL (FIL-SSF, Soleko, Italy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2023
CompletedFirst Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedMarch 8, 2024
March 1, 2024
12 months
March 9, 2023
March 7, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Tilt
Postoperative Tilt
6 Weeks
Autorefraction
Refraction using an automated refractor
6 Weeks
Subjective Refraction
Refraction performed by experienced staff
6 Weeks
Best corrected visual acuity
Measurement performed by experienced staff
6 Weeks
uncorrected visual acuity
Measurement performed by experienced staff
6 Weeks
Study Arms (2)
Carlevale
Patients who had a Carlevale lens implanted
Yamane
Patients who had a lens implanted using Yamane technique
Interventions
Eligibility Criteria
Patients recruited all underwent ocular surgery with implantation of a scleral fixated lens, either using the Carlevale lens or the Yamane technique
You may qualify if:
- minimum age of 21 years
- planned surgery or already taken place surgery using a scleral fixated lens
You may not qualify if:
- best corrected visual acuity \<0.05 Snellen
- pregnancy
- missing informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, 4020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nino Hirnschall, MD
Johannes Kepler University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
March 22, 2023
Study Start
January 19, 2023
Primary Completion
January 1, 2024
Study Completion
January 30, 2024
Last Updated
March 8, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share